» Articles » PMID: 37875562

The Prevalence and Predictive Factors of Nocturnal Polyuria in Japanese Patients with Nocturia: a Multicentral Retrospective Cohort Study

Abstract

The aims of this study were to determine the prevalence and predictors of nocturnal polyuria (NP) in Japanese patients. This multicentral, observational study enrolled patients with the chief complaint of nocturia at 17 Japanese institutions between January 2018 and December 2022. The frequency of daily voiding and volume of urination were evaluated using bladder diaries. NP was diagnosed in patients with an NP index of > 33%. The primary endpoint was NP prevalence in patients with nocturia. The secondary endpoints were the prevalence of NP according to sex and age and the identification of factors predicting NP. This study analyzed 875 eligible patients. NP was present in 590 (67.4%) patients, with prevalence rates of 66.6% and 70.0% in men and women, respectively. Age ≥ 78 years, body mass index (BMI) < 23.0 kg/m, and patients with ischemic heart or cerebrovascular disease were significant predictors of NP (P < 0.001, P < 0.001, P = 0.014, P = 0.016, respectively). This is the first large multicenter study to investigate the prevalence of NP in Japanese patients with nocturia. NP has a prevalence of 67.4%. Significant predictors of NP include age, BMI, and cardiovascular disease.

Citing Articles

Prediction of nocturnal polyuria in patients with nocturia based on voiding frequency.

Nishiwaki T, Kawase K, Nishino Y, Matsuoka K, Ihara T, Makabe S Int Urol Nephrol. 2025; .

PMID: 39956876 DOI: 10.1007/s11255-025-04402-8.


Prevalence and relevant factors of nocturia and its impact on sleep quality in Chinese university students.

Liu Y, Zhang Z, Hu H, He X, Xu P, Qifeng Dou Sci Rep. 2024; 14(1):13883.

PMID: 38880809 PMC: 11180657. DOI: 10.1038/s41598-024-60656-9.

References
1.
Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982; 5(6):649-55. View

2.
Andersson F, Anderson P, Holm-Larsen T, Piercy J, Everaert K, Holbrook T . Assessing the impact of nocturia on health-related quality-of-life and utility: results of an observational survey in adults. J Med Econ. 2016; 19(12):1200-1206. DOI: 10.1080/13696998.2016.1211136. View

3.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P . Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2019; 395(10226):795-808. PMC: 8006904. DOI: 10.1016/S0140-6736(19)32008-2. View

4.
Lose G, Lalos O, Freeman R, Van Kerrebroeck P . Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol. 2003; 189(4):1106-13. DOI: 10.1067/s0002-9378(03)00593-3. View

5.
Chang S, Lin A, Chen K, Chang L . Multifactorial nature of male nocturia. Urology. 2006; 67(3):541-4. DOI: 10.1016/j.urology.2005.09.037. View